The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dr. C. Tuna Resurface Essential Day Cream
Homosalate, Octinoxate, Octocrylene, Avobenzone · HOMOSALATE 70 mg/mL; OCTINOXATE 50 mg/mL; OCTOCRYLENE 50 mg/mL; AVOBENZONE 20 mg/mL · Cream · Topical · Farmasi US LLC
NDC 74690-0016-01 · 1 JAR in 1 BOX / 50 mL in 1 JAR · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Homosalate, Octinoxate, Octocrylene, Avobenzone (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Farmasi US LLC | HOMOSALATE 70 mg/mL; OCTINOXATE 50 mg/mL; OCTOCRYLENE 50 mg/mL; AVOBENZONE 20 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Farmasi US LLC | HOMOSALATE 20 mg/mL; OCTINOXATE 70 mg/mL; OCTOCRYLENE 50 mg/mL; AVOBENZONE 50 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Farmasi US LLC | AVOBENZONE 20 mg/mL; HOMOSALATE 70 mg/mL; OCTINOXATE 50 mg/mL; OCTOCRYLENE 50 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dr. C. Tuna Resurface Essential Day Cream — NDC 74690-0016-01," retrieved September 3, 2026, https://drugdashboards.com/drug/74690001601.
Free to cite with attribution — see how the data is put together.